School of Medicine
Showing 11-20 of 533 Results
-
Ron Albucher, M.D.
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Ronald Albucher is the former Director of Counseling and Psychological Services at Vaden Health Center. His undergraduate training was at University of Pennsylvania and he attended University of Michigan for medical school and residency. Dr. Albucher subsequently joined the faculty at the University of Michigan Medical School’s Department of Psychiatry, where he specialized in Anxiety Disorders, Mental Health treatment of university residents and medical students, and also ran the Ann Arbor VA Medical Center’s Mental Health Clinic. Dr. Albucher was the Associate Training Director, University of Michigan, Department of Psychiatry for approximately 10 years. Ron has been very involved in organized psychiatry, holding numerous positions with the American Psychiatric Association, Michigan Psychiatric Society, and the Northern California Psychiatric Society.
Ron joined Stanford University in September 2008, when he became Director of Counseling and Psychological Services, and a Clinical Associate Professor of Psychiatry in the Medical School’ s Department of Psychiatry. Dr. Albucher has presented at a variety of conferences, published two books on Board Review, and has published scientific research in peer reviewed journals. He continues to serve on the review boards of several journals and publications and is working on two projects currently: eBridge to Wellness (a multisite study of online based outreach to at risk college students), and investigating the implementation of a short-term psychotherapy model in college counseling centers. He stepped down from the Director position in September 2018. -
Amy Alexander
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsCollege Mental Health, Emotional Support Animals & Service Animals, Women's Health, Mental Health & Well-being in Veterinarians
-
Neal Amin
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioNeal D. Amin, MD, PhD is a practicing Stanford psychiatrist and neurobiologist who studies human cellular neurodevelopment - the process by which genetic and molecular pathways give rise to immense cellular diversity in the human brain during embryonic development. A more complete understanding of human cellular neurodevelopment will lead to the next generation of targeted therapeutics for wide ranging neuropsychiatric conditions.
Dr. Amin completed his graduate work with Professor Samuel Pfaff (Salk Institute) where he investigated the regulatory dynamics of a miRNA associated with neurodegeneration using mouse genetic models, single cell RNA sequencing, in vivo CRISPR/Cas9, and linear and non-linear models of the impact of gene dose variation on neurodevelopment and mammalian survival (see: Amin, N.D., et al., Science, 2015; Amin, N.D.*, et al., Neuron 2021, Amin, N.D.*, et al. STAR Protocols; *co-corresponding author). At Stanford, Dr. Amin worked with Stanford Professor Sergiu Pasca, MD to use stem-cell derived human brain organoids as model of neurodevelopment and pathophysiology of psychiatric disorders such as 22q11 deletion syndrome and motor neuron diseases. Human brain organoids are three dimensional cellular models of the human nervous system that recapitulate complex macrostructural and cellular features of the human brain. He published a highly cited review on the utility of human brain organoid technology for studying psychiatric disorders (Amin, N.D., and Pasca, S.P. Neuron, 2018). Dr. Amin is principal investigator on awards from the NIH/NINDS (K08 Career Development Award) and the Brain and Behavior Research Foundation (NARSAD Young Investigator Award). He has particular interest in leveraging cutting-edge biological technologies and bioinformatics to advance the investigation of neurological and psychiatric disorders.
Dr. Amin completed the Stanford Psychiatry Research Track Residency Program and completed the Palo Alto Psychoanalytic Psychotherapy Training Program Fellowship Year. He was recognized with the Outstanding Resident Award from the NIMH/NIH for his academic contributions. He recognizes the critical importance of advancing human neuroscience for the countless patients and families suffering from neuropsychiatric disorders that lack effective treatments. He is a practicing therapist and psychiatrist in Stanford's Evaluation Clinic. -
Bruce Arnow, Ph.D.
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult)
Current Research and Scholarly InterestsCurrent research interests include treatment outcome for major depression, particularly treatment refractory and chronic forms of major depression, as well as mediators and moderators of outcome; the epidemiology of chronic pain and depression; relationships between child maltreatment and adult sequelae, including psychiatric, medical and health care utilization.
-
Ryan T. Ash
Clinical Scholar, Psychiatry and Behavioral Sciences
Postdoctoral Medical Fellow, PsychiatryBioI am a T32 research fellow and research track resident in the Stanford Adult Psychiatry Residency program. During my MD-PhD (Baylor College of Medicine) and postdoc (Harvard Medical School) I studied learning-associated synaptic plasticity and sensory processing in a model of syndromic autism with in vivo 2-photon imaging. I am currently developing methods to study the regulation of synaptic plasticity by attention, affective state and mindful presence, using neuronavigated transcranial magnetic stimulation, transcranial ultrasound stimulation, and EEG steady-state visual-evoked potentials. I won the 2022 Brain Behavior Research Foundation Young Investigator Award to develop in-human applications of ultrasound stimulation in the fear regulation circuit. I am also co-leading the Wellcome LEAP multisite rTMS clinical trial for anhedonic depression in the Stanford Brain Stimulation Lab. I work closely with mentors Anthony Norcia, Kim Butts Pauly, and Nolan Williams on these projects. My clinical interests include integrated psychodynamic- and mindfulness-based approaches, psychedelic-assisted psychotherapy, and neuromodulation-assisted psychotherapy. I am an experienced mindfulness meditation practitioner with more than a year of silent retreat experience.
